Marshall Wace, LLP KERYX BIOPHARM Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
N/A
-16,675 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
N/A
16,675 New
16,675 $57,000
Q2 2018

Aug 14, 2018
SELL
N/A
-59,700 Closed
0 $0
Q1 2018

May 15, 2018
BUY
N/A
59,700 New
59,700 $244,000
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email